Morgan Stanley’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,725
| Closed | -$3K | – | 8111 |
|
|
2022
Q3 | $3K | Sell |
10,725
-1
| -0% | – | ﹤0.01% | 7437 |
|
|
2022
Q2 | $4K | Sell |
10,726
-1,407
| -12% | -$525 | ﹤0.01% | 7489 |
|
|
2022
Q1 | $8K | Sell |
12,133
-1,774
| -13% | -$1.17K | ﹤0.01% | 7486 |
|
|
2021
Q4 | $32K | Buy |
13,907
+3,215
| +30% | +$7.4K | ﹤0.01% | 7018 |
|
|
2021
Q3 | $49K | Sell |
10,692
-7,363
| -41% | -$33.7K | ﹤0.01% | 6740 |
|
|
2021
Q2 | $80K | Buy |
18,055
+8,991
| +99% | +$39.8K | ﹤0.01% | 6452 |
|
|
2021
Q1 | $66K | Sell |
9,064
-14,671
| -62% | -$107K | ﹤0.01% | 6219 |
|
|
2020
Q4 | $181K | Buy |
23,735
+16,607
| +233% | +$127K | ﹤0.01% | 5645 |
|
|
2020
Q3 | $65K | Buy |
7,128
+413
| +6% | +$3.77K | ﹤0.01% | 5620 |
|
|
2020
Q2 | $56K | Buy |
6,715
+3,253
| +94% | +$27.1K | ﹤0.01% | 5644 |
|
|
2020
Q1 | $17K | Sell |
3,462
-39,741
| -92% | -$195K | ﹤0.01% | 5875 |
|
|
2019
Q4 | $311K | Buy |
43,203
+39,505
| +1,068% | +$284K | ﹤0.01% | 5194 |
|
|
2019
Q3 | $40K | Buy |
3,698
+3,670
| +13,107% | +$39.7K | ﹤0.01% | 5809 |
|
|
2019
Q2 | $0 | Sell |
28
-1,411
| -98% | – | ﹤0.01% | 6818 |
|
|
2019
Q1 | $14K | Sell |
1,439
-10,985
| -88% | -$107K | ﹤0.01% | 6115 |
|
|
2018
Q4 | $129K | Buy |
+12,424
| New | +$129K | ﹤0.01% | 5449 |
|